This presentation updates the APN's current knowledge about marijuana and CBD to allow informed dialogue with patients. APNs need to understand the changing landscape around these products with practical knowledge on legal issues, current research, pharmacological actions and effects including safety and efficacy, potential medical uses, and available preparations.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 10/18/22.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.
Faculty, Planners, and Speakers Conflict of Interest Disclosure:
Planning Committee Disclosures:
Christina Hegan, MS, APRN, WHNP-BC
Consultant for Urovant Sciences
Spouse is a distributor for CBD rich hemp oil
There are no other Planning Committee disclosures to declare.
Speakers Conflict of Interest Disclosure:
There are no speaker disclosures to declare.
Commercial Support and Sponsorship:
No commercial support or sponsorship declared.
Accreditation Statement:
Society of Urologic Nurses and Associates (SUNA) is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
The SUNA accreditation is reciprocal in the states and specialty organizations that recognize the ANCC-COA accreditation process. SUNA is also a provider approved by the California Board of Registered Nursing, Provider Number CEP 5556. Accreditation and approved provider status of CE in nursing does not imply ANCC-COA approval or endorsement of any product, advertising, or educational content. SUNA urges all participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.
Learning Outcome:
After completing this education activity, the learner will be able to describe the endocannabinoid system and the pharmacological actions of medical cannabis products along with the appropriate medical uses.
This presentation details the series of escalating safety actions by the U.S. Food and Drug Administration (FDA) from 2008 to the present related to use of surgical mesh intended for transvaginal repair of pelvic organ prolapse. Many questions arise and are explored, including: Might regulations change again in light of emerging availability of post market surveillance studies ("522 Studies") and new randomized controlled trials? Most importantly, how should we be counseling our patients moving forward?
Continuing Education Instructions and Disclosure Information:
Contact hours available until 10/18/22.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.
Faculty, Planners, and Speakers Conflict of Interest Disclosure:
Planning Committee Disclosures:
Christina Hegan, MS, APRN, WHNP-BC
Consultant for Urovant Sciences
Spouse is a distributor for CBD rich hemp oil
There are no other Planning Committee disclosures to declare.
Speakers Conflict of Interest Disclosure:
David D. Rahn, MD
Research Support from Pfizer, Inc.
Grant Support from NIH (NICHD and NIA)
There are no other speaker disclosures to declare.
Commercial Support and Sponsorship:
No commercial support or sponsorship declared.
Accreditation Statement:
Society of Urologic Nurses and Associates (SUNA) is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
The SUNA accreditation is reciprocal in the states and specialty organizations that recognize the ANCC-COA accreditation process. SUNA is also a provider approved by the California Board of Registered Nursing, Provider Number CEP 5556. Accreditation and approved provider status of CE in nursing does not imply ANCC-COA approval or endorsement of any product, advertising, or educational content. SUNA urges all participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.
Learning Outcome:
After completing this education activity, the learner will be able to describe the past, current, and emerging state of the science examining benefits and risks associated with the use of transvaginal mesh for prolapse repair and to be able to effectively counsel patients on their surgical options moving forward.
Advanced prostate cancer treatments continue to evolve with new treatments in the M0CRPC, such as daralutamide and apalutamide, precision treatments based on genetic testing including PARP inhibitors and PD1 immunotherapy. Genetic testing is helping to guide treatment and identify high risk familial genetic traits to help identify appropriate screening for family members. This presentation covers these topics and new breakthroughs.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 10/18/22.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.
Faculty, Planners, and Speakers Conflict of Interest Disclosure:
Planning Committee Disclosures:
Christina Hegan, MS, APRN, WHNP-BC
Consultant for Urovant Sciences
Spouse is a distributor for CBD rich hemp oil
There are no other Planning Committee disclosures to declare.
Speakers Conflict of Interest Disclosure:
Leanne Schimke, MSN, NP, CRNP, CUNP
Speakers Bureau for Bayer and Pfizer
There are no other speaker disclosures to declare.
Commercial Support and Sponsorship:
No commercial support or sponsorship declared.
Accreditation Statement:
Society of Urologic Nurses and Associates (SUNA) is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
The SUNA accreditation is reciprocal in the states and specialty organizations that recognize the ANCC-COA accreditation process. SUNA is also a provider approved by the California Board of Registered Nursing, Provider Number CEP 5556. Accreditation and approved provider status of CE in nursing does not imply ANCC-COA approval or endorsement of any product, advertising, or educational content. SUNA urges all participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.
Learning Outcome:
After completing this education activity, the learner will be able to discuss the reason for genetic testing in men with advanced prostate cancer, implications for their family and use of new prostate cancer medications that are more targeted for their prostate cancer, including PARP inhibitors and the possible side effects to monitor for with their use.
This presentation discusses evidence-based comprehensive evaluation of and treatment for urologic conditions manifested from neurologic disorders including current practice guidelines.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 10/18/22.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.
Faculty, Planners, and Speakers Conflict of Interest Disclosure:
Planning Committee Disclosures:
Christina Hegan, MS, APRN, WHNP-BC
Consultant for Urovant Sciences
Spouse is a distributor for CBD rich hemp oil
There are no other Planning Committee disclosures to declare.
Speakers Conflict of Interest Disclosure:
Gina Powley, MSN, ANP-BC
Speakers Bureau for Astellas
There are no other speaker disclosures to declare.
Commercial Support and Sponsorship:
No commercial support or sponsorship declared.
Accreditation Statement:
Society of Urologic Nurses and Associates (SUNA) is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
The SUNA accreditation is reciprocal in the states and specialty organizations that recognize the ANCC-COA accreditation process. SUNA is also a provider approved by the California Board of Registered Nursing, Provider Number CEP 5556. Accreditation and approved provider status of CE in nursing does not imply ANCC-COA approval or endorsement of any product, advertising, or educational content. SUNA urges all participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.
Learning Outcome:
After completing this education activity, the learner will be able to identify patients with neurogenic bladder and develop a comprehensive treatment plan.
This presentation sets a foundation for understanding of Enhanced Recovery After Surgery (ERAS) concepts and pathways. Discussion of the central tenets of ERAS programs and demonstrating the supporting data for this movement. After establishing basic knowledge, we expand those ideas to urologic specific procedures.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 10/18/22.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.
Faculty, Planners, and Speakers Conflict of Interest Disclosure:
Planning Committee Disclosures:
Christina Hegan, MS, APRN, WHNP-BC
Consultant for Urovant Sciences
Spouse is a distributor for CBD rich hemp oil
There are no other Planning Committee disclosures to declare.
Speakers Conflict of Interest Disclosure:
There are no speaker disclosures to declare.
Commercial Support and Sponsorship:
No commercial support or sponsorship declared.
Accreditation Statement:
Society of Urologic Nurses and Associates (SUNA) is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
The SUNA accreditation is reciprocal in the states and specialty organizations that recognize the ANCC-COA accreditation process. SUNA is also a provider approved by the California Board of Registered Nursing, Provider Number CEP 5556. Accreditation and approved provider status of CE in nursing does not imply ANCC-COA approval or endorsement of any product, advertising, or educational content. SUNA urges all participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.
Learning Outcome:
After completing this education activity, the learner will be able to discuss the central tenets of ERAS programs and demonstrate the supporting data for this movement and expand those ideas to urologic specific procedures.
This presentation serves to improve the knowledge, skill, and comfort in providing care to transgender individuals. Review of the basics of a clinical pathway and review of experience in providing care to this patient population.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 10/18/22.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.
Faculty, Planners, and Speakers Conflict of Interest Disclosure:
Planning Committee Disclosures:
Christina Hegan, MS, APRN, WHNP-BC
Consultant for Urovant Sciences
Spouse is a distributor for CBD rich hemp oil
There are no other Planning Committee disclosures to declare.
Speakers Conflict of Interest Disclosure:
Jennifer Wimberly, MD
Board of Directors – Resource Center, Primary Care Clinic, LGBTQ Health
There are no other speaker disclosures to declare.
Commercial Support and Sponsorship:
No commercial support or sponsorship declared.
Accreditation Statement:
Society of Urologic Nurses and Associates (SUNA) is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
The SUNA accreditation is reciprocal in the states and specialty organizations that recognize the ANCC-COA accreditation process. SUNA is also a provider approved by the California Board of Registered Nursing, Provider Number CEP 5556. Accreditation and approved provider status of CE in nursing does not imply ANCC-COA approval or endorsement of any product, advertising, or educational content. SUNA urges all participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.
Learning Outcome:
After completing this education activity, the learner will be able to demonstrate compassionate care to transgender individuals through acquiring knowledge, skill, and comfort in providing care to this patient population.
Both Electrical Stimulation (E-stim), vaginal and anal, and percutaneous tibial nerve stimulation (PTNS) are discussed. Use of E-stim for urinary and fecal incontinence, urinary retention, constipation, pelvic pain, and sexual dysfunction are explored. Indications, contraindications, and evidence are presented from literature review. Different types of PTNS are explored and discussed (Labori, Medtronic vs. generic TENS).
Continuing Education Instructions and Disclosure Information:
Contact hours available until 10/18/22.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.
Faculty, Planners, and Speakers Conflict of Interest Disclosure:
Planning Committee Disclosures:
Christina Hegan, MS, APRN, WHNP-BC
Consultant for Urovant Sciences
Spouse is a distributor for CBD rich hemp oil
There are no other Planning Committee disclosures to declare.
Speakers Conflict of Interest Disclosure:
Christina Hegan, MS, APRN, WHNP-BC
Consultant for Urovant Sciences
Spouse is a distributor for CBD rich hemp oil
There are no other speaker disclosures to declare.
Commercial Support and Sponsorship:
No commercial support or sponsorship declared.
Accreditation Statement:
Society of Urologic Nurses and Associates (SUNA) is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
The SUNA accreditation is reciprocal in the states and specialty organizations that recognize the ANCC-COA accreditation process. SUNA is also a provider approved by the California Board of Registered Nursing, Provider Number CEP 5556. Accreditation and approved provider status of CE in nursing does not imply ANCC-COA approval or endorsement of any product, advertising, or educational content. SUNA urges all participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.
Learning Outcome:
After completing this education activity, the learner will be able to cite evidence-based practice for use or non-use of various TENS treatment modalities for pelvic floor conditions to provide patients with proper treatment with TENS modalities when indicated.
This presentation gives comprehensive information on bladder pain syndrome/interstitial cystitis (BPS/IC). It provides the latest updates in management and potential etiologies and discusses multimodal therapies.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 10/18/22.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.
Faculty, Planners, and Speakers Conflict of Interest Disclosure:
Planning Committee Disclosures:
Christina Hegan, MS, APRN, WHNP-BC
Consultant for Urovant Sciences
Spouse is a distributor for CBD rich hemp oil
There are no other Planning Committee disclosures to declare.
Speakers Conflict of Interest Disclosure:
There are no speaker disclosures to declare.
Commercial Support and Sponsorship:
No commercial support or sponsorship declared.
Accreditation Statement:
Society of Urologic Nurses and Associates (SUNA) is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
The SUNA accreditation is reciprocal in the states and specialty organizations that recognize the ANCC-COA accreditation process. SUNA is also a provider approved by the California Board of Registered Nursing, Provider Number CEP 5556. Accreditation and approved provider status of CE in nursing does not imply ANCC-COA approval or endorsement of any product, advertising, or educational content. SUNA urges all participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.
Learning Outcome:
After completing this education activity, the learner will be able to use the American Urological Association algorithm to employ the latest treatments for bladder pain syndrome/ interstitial cystitis (BPS/ IC) and understand the rationale behind the treatments.
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) introduced the concept of prevention as an important priority for women's urologic research as a prelude to supporting the formation of the Prevention of Lower Urinary Tract Symptoms (PLUS) research consortium. Phase 1 of the PLUS consortium is now complete, and this presentation shares the goals and outcomes of completed research projects, highlighting their relevance to urologic nursing.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 10/18/22.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.
Faculty, Planners, and Speakers Conflict of Interest Disclosure:
Planning Committee Disclosures:
Christina Hegan, MS, APRN, WHNP-BC
Consultant for Urovant Sciences
Spouse is a distributor for CBD rich hemp oil
There are no other Planning Committee disclosures to declare.
Speakers Conflict of Interest Disclosure:
Diane Newman, DNP, ANP-BC, BCB-PMD
Speakers Bureau - Prometheus
There are no other speaker disclosures to declare.
Commercial Support and Sponsorship:
No commercial support or sponsorship declared.
Accreditation Statement:
Society of Urologic Nurses and Associates (SUNA) is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
The SUNA accreditation is reciprocal in the states and specialty organizations that recognize the ANCC-COA accreditation process. SUNA is also a provider approved by the California Board of Registered Nursing, Provider Number CEP 5556. Accreditation and approved provider status of CE in nursing does not imply ANCC-COA approval or endorsement of any product, advertising, or educational content. SUNA urges all participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.
Learning Outcome:
After completing this education activity, the learner will be able to apply research related to the PLUS NIH Consortium to clinical practice.
This presentation gives an introduction to telemedicine including when to use telemedicine in your practice, resources to easily incorporate telemedicine, and billing basics.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 10/18/22.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.
Faculty, Planners, and Speakers Conflict of Interest Disclosure:
Planning Committee Disclosures:
Christina Hegan, MS, APRN, WHNP-BC
Consultant for Urovant Sciences
Spouse is a distributor for CBD rich hemp oil
There are no other Planning Committee disclosures to declare.
Speakers Conflict of Interest Disclosure:
There are no speaker disclosures to declare.
Commercial Support and Sponsorship:
No commercial support or sponsorship declared.
Accreditation Statement:
Society of Urologic Nurses and Associates (SUNA) is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
The SUNA accreditation is reciprocal in the states and specialty organizations that recognize the ANCC-COA accreditation process. SUNA is also a provider approved by the California Board of Registered Nursing, Provider Number CEP 5556. Accreditation and approved provider status of CE in nursing does not imply ANCC-COA approval or endorsement of any product, advertising, or educational content. SUNA urges all participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.
Learning Outcome:
After completing this education activity, the learner will be able to establish telemedicine in current practice.